Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02387099
Title Dose EScalation Induction of EvERolimus (Desiree)
Acronym Desiree
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors German Breast Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Sana Klinikum Offenbach / German Breast Group Neu Isenburg Hessen 63263 Germany Details
TU Dresden Dresden Sachsen 01307 Germany Details
Bielefeld 33604 Germany Details
University of Erlangen Erlangen 91054 Germany Details
Essen 45136 Germany Details
Goslar 38642 Germany Details
Hanau 63450 Germany Details
Karlsruhe 76135 Germany Details
Kiel 24105 Germany Details
Köln 50931 Germany Details
Mainz 55131 Germany Details
München 80638 Germany Details
Rotenburg 27356 Germany Details
Weinheim 69469 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field